MedTrace Logo

The Effect of Structured Education on Sexual Function and Sexual Quality of Life

NCT05808959 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 34

Last updated 2024-04-30

No results posted yet for this study

Summary

An active sex life has an important place for the quality of life and is closely related to the increase in the general health level. In this context, a healthy sexual life after TKA surgery can contribute to the general quality of life of the patients. In the pre-TKA period, the sexual activity of female patients was found to be impaired more than men, the relationship between spouses was significantly affected negatively, and in the post-TKA period, general sexual recovery was significantly delayed in female patients compared to men. From this perspective, it is clear that pre- and post-TKA sexual counseling is important when preparing a balanced resumption of sexual activity in female patients after TKA. However, in clinical practice, patients may hesitate to talk about sexual life, and orthopedists and nurses often ignore this.

Conditions

  • Arthropathy of Hip
  • Sexuality
  • Orthopedic Disorder

Interventions

BEHAVIORAL

Education group

After the discharge training given at the clinic in the postoperative period, the participants will be given structured training on sexual health.

Sponsors & Collaborators

  • Ankara University

    lead OTHER

Principal Investigators

  • Hatice ÖNER CENGİZ · Ankara University

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-04-27
Primary Completion
2024-04-05
Completion
2024-04-05

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05808959 on ClinicalTrials.gov